BF Scientific Advisory Board (SAB) visited Helsinki on June 10-11, 2013 and evaluated the...
The first Biocenter Finland (BF) user survey was conducted in March 2013 in order to get...
Biocenter Finland is searching for Director for the period of...
Biocenter Finland Workshop on Innovation will be organized in Helsinki (Biomedicum 1, Haartmaninkatu 8) on Monday, January 23, 2012. The Workshop is open to all researchers interested in the topic.
Background: Throughout the European Union academic research institutes are faced with the problem that promising research findings are considered "too early" to be embraced or licensed by commercial partners, yet "too advanced" to be further nurtured through basic research funding. Internationally, experts often refer to this gap as the "valley of death" as this presents a real obstacle to efficient exploitation of innovations.
Structure and aim of the workshop: Although a lot of effort has been put into smoothening the road from scientific discoveries to commercial exploitation, these efforts have not achieved their goal. Scientists are unhappy because they do not get the type of support they need; e.g. financial support for proof-of-concept validation, technology transfer expertise, advise on intellectual property etc. Although strengthening commercial exploitation of innovations is the leading R&D paradigm of the European Union, statistics show that this culture does not prevail in Europe.
Venue: Biomedicum Helsinki 1, Haartmaninkatu 8, lecture room 3
Time: Monday, January 23, 2011 from 12.30 to 17.00
12.30-12.45 Opening words, Eero Vuorio, Director of Biocenter Finland
12.45-13.45 Part one: What is the problem? In the first part a representative of the Finnish scientific community and a representative of the Finnish drug development community address the question of the major obstacles in commercial exploitation of innovations based their experiences and perspectives.
- Academy professor Mart Saarma, University of Helsinki: "Researcher's view on industrial collaborations and application of scientific findings"
- Dr. Risto Lammintausta, Managing Director of Hormos Medical Ltd: "Finnish bioinventions: perspectives of companies"
13.45-14.45 Part two: How has Finland tried to solve the problem? In the second part a representative from the Ministry of Education and Culture (Dr. Erja Heikkinen, Councellor of Education) and a representative from Tekes (Dr. Jari Toivo, Director at Tekes) will describe how Finland has tried to solve the problem of supporting commercial exploitation of innovations within the legal framework of European Union and national laws, and tell about their strategies to solve the problem. An additional short comment on developments at FIMM (Institute for Molecular Medicine Finland) will be given by Dr. Krister Wennerberg.
14.45-15.00 Coffee break
15.00-16.30 Part three: Examples of European Success Stories. For the third part of the workshop two well known experts representing highly successful technology transfer activities in Europe will share their experiences with us.
- Dr. Gabor Lamm, Managing Director of EMBLEM Technology Transfer GmbH, Heidelberg, Germany: "Innovation Works™ by EMBLEM"
- Dr. Rudy Dekeyser, Managing Director at VIB [Vlaams Instituut voor Biotechnologie], Zwijnaarde, Belgium
16.30-17.00 General discussion: How to improve the technology transfer in the field of life sciences in Finland? As this is one of the original tasks set for Biocenter Finland in 2009, we would be particularly interested in hearing opinions of a potential role for Biocenter Finland in smoothening the rocky road from innovations and basic research to their commercial exploitation.
Registration closed. There is no registration fee.
Certificates of participation will be provided on request. Indicate the need of certificate in the registration form. The certificates will be distributed to the participants right after the seminar outside the lecture room.
For more information please contact Director Eero Vuorio, eero.vuorio(at)helsinki.fi, gsm. +358 50 415 6595 or Planning officer Sanna Leinonen, sanna.p.leinonen(at)helsinki.fi, gsm. +358 50 415 6727.
No upcoming events.
Course contents include: cross-technology structural data integration methods, computational modelling and protein design, macromolecular complex production, electron tomography and correlative imaging techniques, biomolecular interactions, hybrid approaches in structural biology.
Biocenter Finland Infrastructure Day, October 13, 2011